Cargando…
DHH-RHEBL1 fusion transcript: a novel recurrent feature in the new landscape of pediatric CBFA2T3-GLIS2-positive acute myeloid leukemia
Childhood Acute Myeloid Leukemia (AML) is a clinically and genetically heterogeneous malignant disease. Despite improvements in outcome over the past decades, the current survival rate still is approximately 60-70%. Cytogenetic, recurrent genetic abnormalities and early response to induction treatme...
Autores principales: | Masetti, Riccardo, Togni, Marco, Astolfi, Annalisa, Pigazzi, Martina, Manara, Elena, Indio, Valentina, Rizzari, Carmelo, Rutella, Sergio, Basso, Giuseppe, Pession, Andrea, Locatelli, Franco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3858557/ https://www.ncbi.nlm.nih.gov/pubmed/24127550 |
Ejemplares similares
-
Hh/Gli antagonist in acute myeloid leukemia with CBFA2T3-GLIS2 fusion gene
por: Masetti, Riccardo, et al.
Publicado: (2017) -
CD56, HLA‐DR, and CD45 recognize a subtype of childhood AML harboring CBFA2T3‐GLIS2 fusion transcript
por: Zangrando, Andrea, et al.
Publicado: (2021) -
CBFA2T3‐GLIS2‐positive acute myeloid leukaemia. A peculiar paediatric entity
por: Masetti, Riccardo, et al.
Publicado: (2018) -
Identification of the NUP98-PHF23 fusion gene in pediatric cytogenetically normal acute myeloid leukemia by whole-transcriptome sequencing
por: Togni, Marco, et al.
Publicado: (2015) -
CBFA2T3::GLIS2‐positive acute leukemia with RAM and mixed T/megakaryocytic phenotype
por: Khanlari, Mahsa, et al.
Publicado: (2023)